Table 1.
Patient Demographics.
| Clinical/Demographic Characteristics | Proportion of Patients | |
|---|---|---|
| Ntot =91 | NRT = 22 | |
| Female (%) | 30 (33.0) | 8 (36.4) |
| Race (%) | ||
| White | 66 (72.5) | 18 (81.8) |
| Black | 2 (2.2) | 0 (0) |
| Asian | 8 (8.8) | 1 (4.6) |
| Other | 14 (15.4) | 3 (13.6) |
| Unknown | 1 (1.1) | 0 (0) |
| Tumor pathology (%) | ||
| WHO I Pilocytic Astrocytoma | 1 (1.1) | 1 (4.5) |
| WHO II Oligodendroglioma | 7 (7.7) | 5 (22.8) |
| WHO II Astrocytoma | 8 (8.8) | 7 (31.8) |
| WHO II Oligoastrocytoma | 2 (2.2) | 2 (9.1) |
| WHO III Anaplastic Oligodendroglioma | 11 (12.1) | 2 (9.1) |
| WHO III Anaplastic Astrocytoma | 14 (15.4) | 0 (0) |
| WHO III Oligoastrocytoma | 4 (4.4) | 1 (4.5) |
| WHO IV Glioblastoma | 33 (36.2) | 2 (9.1) |
| Other | 11 (12.1) | 2 (9.1) |
| Tumor location (%) | ||
| Frontal | 46 (50.5) | 11 (50.0) |
| Temporal | 19 (20.9) | 4 (18.3) |
| Parietal | 6 (6.6) | 2 (9.1) |
| Frontotemporal | 5 (5.5) | 1 (4.5) |
| Frontoparietal | 4 (4.4) | 1 (4.5) |
| Occipital, Cerebellum or Brainstem | 7 (7.7) | 1 (4.5) |
| Other | 4 (4.4) | 2 (9.1) |
| Radiation (%) | 91 (100) | - |
| >1 treatment due to recurrence | 9 (9.9) | - |
| Age at radiation therapy, median (range) | 44 (26-73) | - |
| Chemotherapy (%) | 81 (89.0) | 10 (45.5) |
| Time since RT, year median (range) | 5.33 (.02 - 35) | - |
| Surgical resection (%) | 77 (84.6) | 21 (95.4) |
| >1 surgery due to recurrence | 21 (23.1) | 8 (36.4) |